Navigation Links
Vitreoretinal Viscodissector 45 degrees

ProductsVitreoretinal Viscodissector 45 degrees
Company Hurricane Medical
Item Vitreoretinal Viscodissector 45 degrees
Features 
Description Product designed specifically for posteror segment surgical procedures. For dissection of vitreoretinal membrames using viscoelastic fluid. A high pressure luer lock tubing set is attached to cannula. Tubing is 8in (20cm) long. ID - .02in (.50mm); OD - .06in (1.5mm) and capable of with standing injections of viscoelastic fluids. 30G (.30mm) tip, flattened. Angled 45 degrees, 1mm from end.
Info Hurricane Medical
Customer Service: (877) 446-1444

Related medicine products :

1. Vitreoretinal Micro Cannula
2. Vitreoretinal Injection Cannula
3. Vitreoretinal Injection Cannula - Angled
4. Vitreoretinal Viscodissector
5. Vitreoretinal Micro Pick
6. BD Visitec Vitreoretinal Cannulas
7. Vitreoretinal Viscodissector 90 degrees
8. Vitreoretinal Viscodissector 70 degrees
9. Micro Vitreoretinal Cannula Angled
10. BD Visitec Delaminators and Viscodissectors
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
This is a perfect tool for retrieving free floating sections from the Vibratome bath.
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray.
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi
Medicine Products:
(Date:11/21/2008)...alif., Nov. 21 Album Creative Stud...unches a new program offering big brand marketing ...e large, expensive ad agency process and services,... hands-on approach," says Matt Parker, Creative Di...es experience and proven brand-building techniques...
(Date:11/21/2008)... Fla. -- A Florida State University College of Med...vered an important new layer of regulation in the ... understanding of the way cancer begins. , Wang,...the College of Medicine, said the findings will le...ould lead to the design of new drugs that kill can...
(Date:11/21/2008)...ov. 21 The Providence Se...ed that Craig A. Norris, the Company,s,Chief Oper... Board of,Directors. Mr. Norris, appointment fil... of Steven I. Geringer and returns the board to si...ittee of the Board. , Mr. Norris, age 41, h...
(Date:11/21/2008)...e day lead to a novel technique to combat cancer, ...thDay News) -- Belgian researchers have discovered... sugar for food, and this might lead to new treatm...vive and proliferate, all cells in the body need t...lucose], a process that requires oxygen. Compared ...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...leadership in the companion fields of stem cell re...of Wisconsin-Madison will establish a new Stem Cel...ent of the new center, to be made today (May 17) a...ental biologist Ian Wilmut, the creator of the clo...
...uffer in silence, cough up more money to get thing...lts. And here comes the news that a hospital grou...its workmanship, charging a flat fee that includes...nt. Even if a patient suffers complications or ha...
...are, Dr. David Parirenyatwa, says that the illegal...verely compromised the country's health delivery ... World Health Assembly in Geneva, Switzerland, to ...onditional lifting of these sanctions. He calls t...
... response to numerous complaints over local health...tient clinic in Evansville city that would open b...ut 87,000 square feet that must be available for o...l veterans have complained for nearly two years ab...
Other Medicine News:Health News:UW Establishes Stem Cell and Regenerative Medicine Center 2Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Sanctions Imposed On Zimbabwe Can Threaten International Health Security 2
(Date:11/20/2008)...mber 20 Arpida (SWX:,AR...Advisory Committee of the,U.S. Food and Drug Admi...proval of intravenous iclaprim, an antibiotic curr...s with complicated skin and skin structure infecti...in-resistant Staphylococcus,aureus (MRSA). , ...
(Date:11/20/2008)... -- Clinical data from a prospective,registry pre...m shows DVT,treatment with the Trellis(R) Periphe...Santa Clara, CA) successfully breaks up the blood ... This technique, called isolated pharmacomechani...y and safely than current catheter-directed thromb...
(Date:11/19/2008)...eve statistical significance , , ISELIN, N....poration (Nasdaq: PARS ) today announced results...anoEmulsion (NE) drug delivery technology formulat...he multi-center, randomized, double-blinded, place...acy of the Company,s 3% Diclofenac Diethanolamine ...
(Date:11/18/2008)...e-FirstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a ...evelopment Company,and Sosei Group Corporation (...rnational biopharmaceutical company, today announc...al pre-clinical efficacy data for NSL-043/SD118.,...or neuropathic pain and has,successfully complete...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Nicotine Plus Alcohol May Be Tough to Beat 5651 1Nicotine Plus Alcohol May Be Tough to Beat 5651 2Nicotine Plus Alcohol May Be Tough to Beat 5651 3AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 1AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 2Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 1Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 2MicroActive Corporation Acquired by Linden and Edgewater 5649 1MicroActive Corporation Acquired by Linden and Edgewater 5649 2
...ies Presented at ECCMID/ICC, MUNICH, Germany, Apri...oday announced results from two studies showing th...l growth in vitro,when tested with a common wettin...ng the activity of oritavancin against S.,pneumoni...ovel,lipoglycopeptide antibiotic, is Targanta,s le...
...rBChE Suppresses Amyloid Plaque,Formation , ANNAPO...ding,biodefense company specializing in the develo...ures against chemical and,biological terrorism, an...utyrylcholinesterase (rBChE) research program were...rence on,Alzheimer,s and Parkinson,s Diseases in S...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6